{"id":"https://openalex.org/W2584533741","doi":"https://doi.org/10.1016/j.jpba.2017.02.005","title":"Solid state characterization of azelnidipine\u2013oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs","display_name":"Solid state characterization of azelnidipine\u2013oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs","publication_year":2017,"publication_date":"2017-02-04","ids":{"openalex":"https://openalex.org/W2584533741","doi":"https://doi.org/10.1016/j.jpba.2017.02.005","mag":"2584533741","pmid":"https://pubmed.ncbi.nlm.nih.gov/28237872"},"language":"en","primary_location":{"id":"doi:10.1016/j.jpba.2017.02.005","doi":"https://doi.org/10.1016/j.jpba.2017.02.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jpba.2017.02.005","pdf_url":null,"source":{"id":"https://openalex.org/S174893293","display_name":"Journal of Pharmaceutical and Biomedical Analysis","issn_l":"0731-7085","issn":["0731-7085","1873-264X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical and Biomedical Analysis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007086351","display_name":"Yahui Pan","orcid":"https://orcid.org/0000-0001-6395-1223","observed_orcids":["https://orcid.org/0000-0001-6395-1223"]},"institutions":[{"id":"https://openalex.org/I111381250","display_name":"Hebei Medical University","ror":"https://ror.org/04eymdx19","country_code":"CN","type":"education","lineage":["https://openalex.org/I111381250"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yahui Pan","raw_affiliation_strings":["School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China","institution_ids":["https://openalex.org/I111381250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038642947","display_name":"Wenzhe Pang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111381250","display_name":"Hebei Medical University","ror":"https://ror.org/04eymdx19","country_code":"CN","type":"education","lineage":["https://openalex.org/I111381250"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenzhe Pang","raw_affiliation_strings":["School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China","institution_ids":["https://openalex.org/I111381250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066922856","display_name":"Jie Lv","orcid":"https://orcid.org/0000-0001-9267-7139","observed_orcids":["https://orcid.org/0000-0001-9267-7139"]},"institutions":[{"id":"https://openalex.org/I111381250","display_name":"Hebei Medical University","ror":"https://ror.org/04eymdx19","country_code":"CN","type":"education","lineage":["https://openalex.org/I111381250"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jie Lv","raw_affiliation_strings":["School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China","institution_ids":["https://openalex.org/I111381250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101929915","display_name":"Jing Wang","orcid":"https://orcid.org/0000-0002-7412-6322","observed_orcids":["https://orcid.org/0000-0002-7412-6322"]},"institutions":[{"id":"https://openalex.org/I111381250","display_name":"Hebei Medical University","ror":"https://ror.org/04eymdx19","country_code":"CN","type":"education","lineage":["https://openalex.org/I111381250"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jing Wang","raw_affiliation_strings":["School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China. Electronic address: jingwang@home.ipe.ac.cn","School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China. Electronic address: jingwang@home.ipe.ac.cn","institution_ids":["https://openalex.org/I111381250"]},{"raw_affiliation_string":"School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China","institution_ids":["https://openalex.org/I111381250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101496874","display_name":"Caiqin Yang","orcid":"https://orcid.org/0000-0002-4113-7631","observed_orcids":["https://orcid.org/0000-0002-4113-7631"]},"institutions":[{"id":"https://openalex.org/I111381250","display_name":"Hebei Medical University","ror":"https://ror.org/04eymdx19","country_code":"CN","type":"education","lineage":["https://openalex.org/I111381250"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Caiqin Yang","raw_affiliation_strings":["School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China","institution_ids":["https://openalex.org/I111381250"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003030898","display_name":"Wei Feng Guo","orcid":"https://orcid.org/0000-0003-1189-5682","observed_orcids":["https://orcid.org/0000-0003-1189-5682"]},"institutions":[{"id":"https://openalex.org/I111381250","display_name":"Hebei Medical University","ror":"https://ror.org/04eymdx19","country_code":"CN","type":"education","lineage":["https://openalex.org/I111381250"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Guo","raw_affiliation_strings":["School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, 050017, China","institution_ids":["https://openalex.org/I111381250"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101929915"],"corresponding_institution_ids":["https://openalex.org/I111381250"],"apc_list":{"value":3680,"currency":"USD","value_usd":3680},"apc_paid":null,"fwci":1.7344,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.81376999,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"138","issue":null,"first_page":"302","last_page":"315"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10798","display_name":"Crystallography and molecular interactions","score":0.6460000276565552,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10798","display_name":"Crystallography and molecular interactions","score":0.6460000276565552,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.32179999351501465,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/azelnidipine","display_name":"azelnidipine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/oxalic-acid","display_name":"oxalic acid","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cocrystals","display_name":"cocrystals","score":0.902999997138977},{"id":"https://openalex.org/keywords/polymorphism","display_name":"polymorphism","score":0.7350000143051147},{"id":"https://openalex.org/keywords/solvent-assisted-grinding","display_name":"solvent-assisted grinding","score":0.9129999876022339},{"id":"https://openalex.org/keywords/hydrogen-bonding","display_name":"hydrogen bonding","score":0.49300000071525574},{"id":"https://openalex.org/keywords/dissolution-rate","display_name":"dissolution rate","score":0.5690000057220459},{"id":"https://openalex.org/keywords/solubility-enhancement","display_name":"solubility enhancement","score":0.777999997138977},{"id":"https://openalex.org/keywords/drug-solubility","display_name":"drug solubility","score":0.4339999854564667},{"id":"https://openalex.org/keywords/intermolecular-interactions","display_name":"intermolecular interactions","score":0.6380000114440918},{"id":"https://openalex.org/keywords/heat-of-fusion","display_name":"heat of fusion","score":0.6620000004768372},{"id":"https://openalex.org/keywords/specific-heat-capacity","display_name":"specific heat","score":0.6499999761581421},{"id":"https://openalex.org/keywords/solid-state-characterization","display_name":"solid-state characterization","score":0.546999990940094},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.6990000009536743},{"id":"https://openalex.org/keywords/drug-formulation-optimization","display_name":"drug formulation optimization","score":0.30399999022483826},{"id":"https://openalex.org/keywords/pharmaceutical-excipients","display_name":"pharmaceutical excipients","score":0.33500000834465027}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7175599336624146},{"id":"https://openalex.org/C2781346138","wikidata":"https://www.wikidata.org/wiki/Q184832","display_name":"Oxalic acid","level":2,"score":0.6756613254547119},{"id":"https://openalex.org/C56052488","wikidata":"https://www.wikidata.org/wiki/Q103382","display_name":"Amorphous solid","level":2,"score":0.6737281084060669},{"id":"https://openalex.org/C2781285689","wikidata":"https://www.wikidata.org/wiki/Q21921428","display_name":"Crystal (programming language)","level":2,"score":0.6202741861343384},{"id":"https://openalex.org/C39519442","wikidata":"https://www.wikidata.org/wiki/Q904893","display_name":"Differential scanning calorimetry","level":2,"score":0.6011161804199219},{"id":"https://openalex.org/C8010536","wikidata":"https://www.wikidata.org/wiki/Q160398","display_name":"Crystallography","level":1,"score":0.5952841639518738},{"id":"https://openalex.org/C160892712","wikidata":"https://www.wikidata.org/wiki/Q901559","display_name":"Fourier transform infrared spectroscopy","level":2,"score":0.5127490758895874},{"id":"https://openalex.org/C153642686","wikidata":"https://www.wikidata.org/wiki/Q70906","display_name":"Infrared spectroscopy","level":2,"score":0.46137723326683044},{"id":"https://openalex.org/C115624301","wikidata":"https://www.wikidata.org/wiki/Q895901","display_name":"Crystal structure","level":2,"score":0.46091488003730774},{"id":"https://openalex.org/C113196181","wikidata":"https://www.wikidata.org/wiki/Q485223","display_name":"Analytical Chemistry (journal)","level":2,"score":0.46003469824790955},{"id":"https://openalex.org/C185039092","wikidata":"https://www.wikidata.org/wiki/Q376044","display_name":"Powder diffraction","level":2,"score":0.4405531883239746},{"id":"https://openalex.org/C179104552","wikidata":"https://www.wikidata.org/wiki/Q11165","display_name":"Inorganic chemistry","level":1,"score":0.20678061246871948},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.11276006698608398},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C97355855","wikidata":"https://www.wikidata.org/wiki/Q11473","display_name":"Thermodynamics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001383","descriptor_name":"Azetidinecarboxylic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D001383","descriptor_name":"Azetidinecarboxylic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002152","descriptor_name":"Calorimetry, Differential Scanning","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D003460","descriptor_name":"Crystallization","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004095","descriptor_name":"Dihydropyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011208","descriptor_name":"Powders","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012997","descriptor_name":"Solvents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013816","descriptor_name":"Thermodynamics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014961","descriptor_name":"X-Ray Diffraction","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D017550","descriptor_name":"Spectroscopy, Fourier Transform Infrared","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D019815","descriptor_name":"Oxalic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D033362","descriptor_name":"Powder Diffraction","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jpba.2017.02.005","doi":"https://doi.org/10.1016/j.jpba.2017.02.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jpba.2017.02.005","pdf_url":null,"source":{"id":"https://openalex.org/S174893293","display_name":"Journal of Pharmaceutical and Biomedical Analysis","issn_l":"0731-7085","issn":["0731-7085","1873-264X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical and Biomedical Analysis","raw_type":"journal-article"},{"id":"pmid:28237872","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28237872","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical and biomedical analysis","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G4694063427","display_name":null,"funder_award_id":"NSFC 81202504","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1516297516","https://openalex.org/W1973960023","https://openalex.org/W1974055924","https://openalex.org/W1983319174","https://openalex.org/W1987161794","https://openalex.org/W1993177816","https://openalex.org/W2000504057","https://openalex.org/W2000654791","https://openalex.org/W2013251375","https://openalex.org/W2024610484","https://openalex.org/W2030941769","https://openalex.org/W2036396946","https://openalex.org/W2042502385","https://openalex.org/W2056434768","https://openalex.org/W2057015058","https://openalex.org/W2071894468","https://openalex.org/W2074864397","https://openalex.org/W2093830704","https://openalex.org/W2127404132","https://openalex.org/W2140392250","https://openalex.org/W2154214542","https://openalex.org/W2155692480","https://openalex.org/W2183838382","https://openalex.org/W2247664950","https://openalex.org/W2270213623","https://openalex.org/W2283544327","https://openalex.org/W2310860732","https://openalex.org/W2315466603","https://openalex.org/W2912406497","https://openalex.org/W4243356458","https://openalex.org/W6682880258"],"related_works":["https://openalex.org/W2093830704","https://openalex.org/W2183838382","https://openalex.org/W4283577661","https://openalex.org/W2890328687","https://openalex.org/W7097992463","https://openalex.org/W2074864397","https://openalex.org/W4403426086","https://openalex.org/W2294180385","https://openalex.org/W4401621719","https://openalex.org/W4406806695"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-02-10T00:00:00"}